This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Bailey, K. P. Search for Related Content Social Bookmarking                         What's this?

Pharmacologic Agents for the Treatment of Schizophrenia: Similarities and Differences

Adult Outpatient Clinic; Department of Psychiatry; New England Medical Center in Boston, Massachusetts; 171 Harrison Ave., Boston, MA 02111.

Although the efficacy of conventional antipsychotic agents is attributed to dopamine receptor antagonism, this blockade induces many adverse effects as welt In addition, conventional antipsychotic agents are relatively ineffective against negative symptoms and have significant rates of nonresponse and relapse. Clozapine and risperidone, "atypical" antipsychotic agents, differ from conventional agents in their receptor-binding profiles and clinical effects. They are effective for acute and treatment-resistant schizophrenia, with different, and perhaps, more tolerable side effect profiles. This article compares the mechanisms of action, efficacy, and adverse effects of the typical and atypical antipsychotic agents.

Journal of the American Psychiatric Nurses Association, Vol. 2, No. 5, 181-185 (1996)
DOI: 10.1177/107839039600200511


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?